Salmonella Paratyphi and multiorgan dysfunction: A rare case report [PDF]
Salmonella typhi (S. typhi) and Salmonella paratyphi A (S. paratyphi A), together known as typhoidal Salmonella, are causal agents for an invasive, serious, and sometimes fatal disease of humans called typhoid fever or paratyphoid fever (also known as ...
Manish Kumar, Ashok Sunder
doaj +4 more sources
Homologous and heterologous re-challenge with Salmonella Typhi and Salmonella Paratyphi A in a randomised controlled human infection model. [PDF]
Enteric fever is a systemic infection caused by Salmonella Typhi or Paratyphi A. In many endemic areas, these serovars co-circulate and can cause multiple infection-episodes in childhood.
Malick M Gibani +24 more
doaj +4 more sources
Lactose Fermenting Salmonella Paratyphi A: A case report [PDF]
There are more than 2500 antigenic types of the genus Salmonella. Typhoid fever is caused by Salmonella typhi, Salmonella paratyphi A, B and C. Characteristically all four of these is non-fermenters of lactose.
Mahwish Latif +5 more
doaj +4 more sources
Characterization and protective efficacy of a sptP mutant of Salmonella Paratyphi A [PDF]
Background Salmonella Paratyphi A causes paratyphoid A, a severe systemic disease of people and remains a major public health problem in many parts of the world.
Pengtao Pan +4 more
doaj +2 more sources
A rare case of Salmonella Paratyphi A endocarditis. [PDF]
Non-typhoid endocarditis is uncommon. Non-typhoid Salmonella paratyphi A endocarditis is even more rare. Although the spectrum of available antibiotics is adequate for treatment, the importance of this condition stresses its rarity of occurrence and presentation. Here, we present the case of a middle-aged male suffering from S. paratyphi A endocarditis.
Narasaraju K +5 more
europepmc +3 more sources
Design of a Glycoconjugate Vaccine Against Salmonella Paratyphi A. [PDF]
Background/Objectives: Typhoid and paratyphoid fever together are responsible for millions of cases and thousands of deaths per year, most of which occur in children in South and Southeast Asia. While typhoid conjugate vaccines (TCVs) are licensed, no vaccines are currently available against S. Paratyphi A. Here we describe the design of a S. Paratyphi
Alfini R +8 more
europepmc +4 more sources
A 23-year retrospective investigation of Salmonella Typhi and Salmonella Paratyphi isolated in a tertiary Kathmandu hospital. [PDF]
Salmonella serovars Typhi (S. Typhi) and Paratyphi A (S. Paratyphi A), the causative agents of enteric fever, have been routinely isolated organisms from the blood of febrile patients in the Kathmandu Valley since the early 1990s.
Raphaël M Zellweger +12 more
doaj +3 more sources
A contemporary genomic snapshot of <i>Salmonella</i> Paratyphi A in Pakistan. [PDF]
Salmonella enterica serovar Paratyphi A is a significant but under-characterised cause of enteric fever in South Asia. In Pakistan, where the typhoid conjugate vaccine has been introduced to combat S . Typhi, S .
Mylona E +10 more
europepmc +2 more sources
Fluoroquinolone-resistant Salmonella Paratyphi A
To the Editor: Fluoroquinolones have been the drug of choice for treating typhoid and paratyphoid fever since the beginning of the 1990s. Multidrug-resistant strains began to prevail in disease-endemic areas, and former first-line antimicrobial drugs, such as chloramphenicol, were sometimes ineffective (1).
Takuya Adachi +3 more
doaj +2 more sources
Identifying the mechanism underlying treatment failure for Salmonella Paratyphi A infection using next-generation sequencing – a case report [PDF]
Background Salmonella is a notorious pathogen that causes gastroenteritis in humans and the emergence of resistance to third-generation cephalosporins and azithromycin have raised concern.
Hye-Ran Park +3 more
doaj +2 more sources

